Cytomegalovirus and glioblastoma; controversies and opportunities

Autologous T-cell Therapy for Cytomegalovirus as a Consolidative Treatment for Recurrent Glioblastoma

(2014) A. Schuessler et al.   CANCER RESEARCH

Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells

(2014) S. K. Nair et al.   CLINICAL CANCER RESEARCH

Does valganciclovir have a role in glioblastoma therapy?

(2014) C. S. Cobbs   NEURO-ONCOLOGY

Response to "Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics"

(2014) C. Cobbs   NEURO-ONCOLOGY

CMV and glioma-are we there yet?

(2014) J. T. Huse et al.   NEURO-ONCOLOGY

CMV infection and glioma, a highly controversial concept struggling in the clinical arena

(2014) W. Wick et al.   NEURO-ONCOLOGY

Human cytomegalovirus infection in tumor cells of the nervous system is not detectable with standardized pathologico-virological diagnostics

(2014) P. Baumgarten et al.   NEURO-ONCOLOGY

Human Cytomegalovirus Tegument Protein pp65 Is Detected in All Intra- and Extra-Axial Brain Tumours Independent of the Tumour Type or Grade

(2014) Sylwia Libard et al.   PLoS One

Immunological targeting of cytomegalovirus for glioblastoma therapy

(2014) Smita K Nair et al.   OncoImmunology

Cytomegalovirus as a Novel Target for Immunotherapy of Glioblastoma Multiforme

(2014) Andrea Schuessler et al.   Frontiers in Oncology

Cytomegalovirus Contributes to Glioblastoma in the Context of Tumor Suppressor Mutations

(2013) R. L. Price et al.   CANCER RESEARCH

Cidofovir: A Novel Antitumor Agent for Glioblastoma

(2013) P. Hadaczek et al.   CLINICAL CANCER RESEARCH

Cytomegalovirus and brain tumor

(2013) Charles S. Cobbs   CURRENT OPINION IN ONCOLOGY

Good maths is needed to understand CMV data in glioblastoma

(2013) Wolfgang Wick et al.   INTERNATIONAL JOURNAL OF CANCER

Effects of valganciclovir as an add-on therapy in patients with cytomegalovirus-positive glioblastoma: A randomized, double-blind, hypothesis-generating study

(2013) Giuseppe Stragliotto et al.   INTERNATIONAL JOURNAL OF CANCER

Immortal time bias in retrospective analysis: Is there a survival benefit in patients with glioblastoma who received prolonged treatment of adjuvant valganciclovir?

(2013) Chia-Jen Liu et al.   INTERNATIONAL JOURNAL OF CANCER

Use of Cox regression with treatment status as a time-dependent covariate to re-analyze survival benefit excludes immortal time bias effect in patients with glioblastoma who received prolonged adjuvant treatment with valganciclovir

(2013) Cecilia Söderberg-Naucler et al.   INTERNATIONAL JOURNAL OF CANCER

Human cytomegalovirus infection levels in glioblastoma multiforme are of prognostic value for survival

(2013) Afsar Rahbar et al.   JOURNAL OF CLINICAL VIROLOGY

NIH mulls rules for validating key results

(2013) Meredith Wadman   NATURE

The legend of cytomegalovirus and glioblastoma lives on

(2013) M. Weller et al.   NEURO-ONCOLOGY

Valganciclovir in Patients with Glioblastoma

(2013)   NEW ENGLAND JOURNAL OF MEDICINE

Survival in Patients with Glioblastoma Receiving Valganciclovir

(2013) Cecilia Söderberg-Nauclér et al.   NEW ENGLAND JOURNAL OF MEDICINE

High Prevalence of Human Cytomegalovirus Proteins and Nucleic Acids in Primary Breast Cancer and Metastatic Sentinel Lymph Nodes

(2013) Chato Taher et al.   PLoS One

Cytomegalovirus Infection Leads to Pleomorphic Rhabdomyosarcomas in Trp53+/- Mice

(2012) R. L. Price et al.   CANCER RESEARCH

Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme

(2012) Tania Crough et al.   IMMUNOLOGY AND CELL BIOLOGY

Generation of Polyclonal CMV-specific T Cells for the Adoptive Immunotherapy of Glioblastoma

(2012) Alexia Ghazi et al.   JOURNAL OF IMMUNOTHERAPY

Genetic Analysis of Cytomegalovirus in Malignant Gliomas

(2012) B. Bhattacharjee et al.   JOURNAL OF VIROLOGY

Consensus on the role of human cytomegalovirus in glioblastoma

(2012) K. Dziurzynski et al.   NEURO-ONCOLOGY

Glioma-Associated Cytomegalovirus Mediates Subversion of the Monocyte Lineage to a Tumor Propagating Phenotype

(2011) K. Dziurzynski et al.   CLINICAL CANCER RESEARCH

Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target

(2011) Ninib Baryawno et al.   JOURNAL OF CLINICAL INVESTIGATION

Significant Association of Multiple Human Cytomegalovirus Genomic Loci with Glioblastoma Multiforme Samples

(2011) P. Ranganathan et al.   JOURNAL OF VIROLOGY

Extensive Genome-Wide Variability of Human Cytomegalovirus in Congenitally Infected Infants

(2011) Nicholas Renzette et al.   PLoS Pathogens

Human Cytomegalovirus Infection Causes Premature and Abnormal Differentiation of Human Neural Progenitor Cells

(2010) M. H. Luo et al.   JOURNAL OF VIROLOGY

HCMV-Encoded Chemokine Receptor US28 Mediates Proliferative Signaling Through the IL-6-STAT3 Axis

(2010) E. Slinger et al.   Science Signaling

Activation of Telomerase by Human Cytomegalovirus

(2009) K. Straat et al.   JNCI-Journal of the National Cancer Institute

Human tumor-associated viruses and new insights into the molecular mechanisms of cancer

(2009) D Martin et al.   ONCOGENE

Papillomaviruses in the causation of human cancers — a brief historical account

(2009) Harald zur Hausen   VIROLOGY

Cytomegalovirus microRNAs

(2009) Lars Dölken et al.   VIRUS GENES

Detection of human cytomegalovirus in different histological types of gliomas

(2008) Michael E. Scheurer et al.   ACTA NEUROPATHOLOGICA

Platelet-derived growth factor-α receptor activation is required for human cytomegalovirus infection

(2008) Liliana Soroceanu et al.   NATURE

Cytomegalovirus Immunity after Vaccination with Autologous Glioblastoma Lysate

(2008) Robert M. Prins et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma

(2007) Duane A. Mitchell et al.   NEURO-ONCOLOGY